Definitive Healthcare vs NRC Health
DH and NRC side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How DH and NRC compare
NRC Health is the larger company, worth 4.2 times as much as Definitive Healthcare ($587M against $140M).
NRC Health grew revenue faster over the last twelve months (3.4% versus −6.2% for Definitive Healthcare).
NRC Health pays a dividend yielding 2.4%; Definitive Healthcare does not pay one.
NRC Health scores higher on the StockData Score (6 against 5 for Definitive Healthcare), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | DH | NRC |
|---|---|---|
| Size and price | ||
| Market cap | $140M | $587M |
| Share price | $1.31 | $26.56 |
| Change, 1 year | −51.8% | 72.1% |
| Change, 5 years | −96.2% | −37.6% |
| Beta (5Y) | 1.85 | 0.51 |
| Employees | 686 | 357 |
| StockData Score | ||
| Total score | 5 | 6 (better) |
| Valuation score | 3 (better) | 0 |
| Growth score | 0 | 1 (better) |
| Performance score | 0 | 1 (better) |
| Health score | 2 | 2 |
| Dividend score | 0 | 2 (better) |
| Valuation | ||
| P/S | 0.6× (better) | 4.1× |
| EV/EBITDA | – | 28.1× |
| P/FCF | 5.8× (better) | 31.8× |
| FCF yield | 17.3% (better) | 3.1% |
| Fair value | $3.95 | $14.70 |
| Margin of safety | 66.8% (better) | −80.6% |
| Growth | ||
| Revenue growth (TTM) | −6.2% | 3.4% (better) |
| Revenue growth, 5Y average | 15.3% (better) | 0.61% |
| EPS growth, 5Y average | – | 103% |
| Profitability | ||
| Gross margin | 75.4% | – |
| Operating margin | −105% | 11.1% (better) |
| Net margin | −69.2% | – |
| FCF margin | 10.6% | 12.8% (better) |
| Return on invested capital | – | 10.9% |
| Financial health | ||
| Net debt / EBITDA | – | 4.07 |
| Interest coverage | −22.2× | 2.9× (better) |
| Current ratio | 1.96 (better) | 0.64 |
| Altman Z-score | −3.24 | 3.42 (better) |
| Piotroski F-score | 5 | – |
| Dividends and buybacks | ||
| Dividend yield | – | 2.4% |
| Years of dividend growth | – | 1 |
| Dividend growth, 5Y average | – | 19.9% |
| Buyback yield | 0.00% | 4.4% (better) |
| Shareholder yield | 0.00% | 6.8% (better) |
| Ownership | ||
| Held by institutions | 81.2% | 48.6% |
| Held by insiders | – | 50.4% |
| Insider net buying, 12 months | – | $98.2K |
| Short interest, % of float | – | 6.3% |
Go deeper
- DH stock overview
- DH income statement
- DH valuation and score
- NRC stock overview
- NRC income statement
- NRC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.